0.1% (dexamethasone ophthalmic suspension)
MAXIDEX® 0.1% (dexamethasone ophthalmic suspension) is an adrenocortical steroid prepared as a sterile topical ophthalmic suspension.
MAXIDEX (DEXAMETHASONE) is indicated for the following:
Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.
Published Studies Related to Maxidex (Dexamethasone Ophthalmic)
A randomized clinical trial of the effects of submucosal dexamethasone after
surgery for mandibular fractures. 
mandibular fractures... CONCLUSION: The results of our study suggest that submucosal administration of
A multi-center, double-blind, randomized, placebo-controlled trial protocol to
assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome:
the TRAumeel in ROtator cuff syndrome (TRARO) study protocol. 
BACKGROUND: Shoulder pain is a common musculoskeletal symptom with a wide range
of potential causes; however, the majority of conditions can be managed with
conservative treatment... DISCUSSION: It is hoped that the results of this trial will expand the treatment
options and evidence base available for the management of rotator cuff disease.
Comparison of local and intravenous dexamethasone for postoperative pain and
recovery after tonsillectomy. 
injection for postoperative pain and recovery after tonsillectomy... CONCLUSION: Local infiltration of dexamethasone was more effective than systemic
Effect of combined dexamethasone therapy with nebulized r-epinephrine or
salbutamol in infants with bronchiolitis: A randomized, double-blind, controlled
bronchodilators alone for the treatment of infants with bronchiolitis... CONCLUSIONS: This study adds to a body of evidence suggesting that
The effects of perineural versus intravenous dexamethasone on sciatic nerve
blockade outcomes: a randomized, double-blind, placebo-controlled study. 
block characteristics... CONCLUSIONS: Preoperative administration of IV and perineural dexamethasone
Clinical Trials Related to Maxidex (Dexamethasone Ophthalmic)
Dexamethasone in Lower Third Molar Surgery [Recruiting]
The aim of this randomized double-blind cross over clinical trial is to investigate
effectiveness of different routes of applications (intramuscular and submucous at the site
of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and
quality of life after lower third molar surgery.
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) [Recruiting]
The project was undertaking by Qilu Hospital of Shandong University and other 7 well-known
hospitals in China. In order to report the efficacy and safety of different dose
dexamethasone in treating the immune thrombocytopenia (ITP).
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting [Recruiting]
Postoperative nausea and vomiting (PONV) are frequent after surgery and anaesthesia.
Dexamethasone is widely used as antiemetic for the prevention of PONV. Little is known about
the efficacy of antiemetic drugs for the treatment of established PONV symptoms. No single
randomised trial has been published so far that tests the efficacy of dexamethasone for the
treatment of established PONV symptoms. In this trial the investigators want to test the
antiemetic efficacy of three different doses of intravenous dexamethasone for the treatment
of established PONV symptoms. In adjunct protocols of this study the investigators aim to
establish a novel method to quantify the anti-nausea efficacy of an antiemetic drug, to
study pharmacogenetics of PONV, and to further our understanding on the smoking status as a
predictive factor of PONV.
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane [Recruiting]
The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant
(Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic
epiretinal membrane (ERM).
Dexamethasone Therapy in VLBW Infants at Risk of CLD [Completed]
Infants who are on breathing support are often treated with steroids (dexamethasone);
however, the best timing of therapy is not known. This trial looked at the benefits and
hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in
Reports of Suspected Maxidex (Dexamethasone Ophthalmic) Side Effects
Intraocular Pressure Increased (5),
Corneal Thickening (3),
Transplant Failure (2),
Post Procedural Complication (2),
Visual Acuity Reduced (2),
Transplant Rejection (2),
Corneal Opacity (2),
Corneal Decompensation (2),
Lens Extraction (1), more >>
Page last updated: 2015-08-10